Dietary macro/micronutritional supplement for patients undergoing kidney dialysis

A kit for a subject (i) with kidney disease or at risk of kidney disease or (ii) undergoing kidney dialysis comprising the following components:

• (a) a unit dose composition consisting of;
• vitamin B1 in the amount of 0.1 mg to 50 mg per unit dose;
• vitamin B2 in the amount of 0.1 mg to 2 mg per unit dose;
• vitamin B3 in the amount of 1 mg to 40 mg per unit dose;
• vitamin B5 in the amount of 1 mg to 20 mg per unit dose;
• vitamin B6 in the amount of 1 mg to 100 mg per unit dose;
• vitamin B7 in the amount of 10 μg to 500 μg per unit dose;
• vitamin B9 in the amount of 0.05 mg to 1.0 mg per unit dose;
• vitamin B12 in the amount of 1 μg to 150 μg per unit dose;
• vitamin C in the amount of 10 mg to 2,000 mg per unit dose;
• a pharmaceutically-acceptable compound of calcium in the amount of 100 mg to 2,500 mg per unit dose;
• vitamin D3 in the amount of 1 μg to 100 μg per unit dose;
• a pharmaceutically-acceptable compound of magnesium in the amount of 100 mg to 500 mg per unit dose;
• a pharmaceutically-acceptable compound of zinc in the amount of 1 mg to 40 mg per unit dose;
• a pharmaceutically-acceptable compound of selenium in the amount of 10 μg to 400 μg per unit dose;
• a pharmaceutically-acceptable compound of iron in the amount of 1 mg to 45 mg per unit dose;
• L-carnitine-L-tartrate or acetyl-L-carnitine;
• maltodextrin;
• and
• optionally a citrus bioflavonoid, powdered extract of cranberry or cherry, or any combination thereof;
• (b) a capsule comprising marine omega 3 fatty acids in the amount of 500 mg to 4,000 mg per unit dose;
• and
• (c) a gel comprising coenzyme Q10 in the amount of 70 mg to 400 mg per unit dose.